Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant and inflammation-modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal, cardiovascular, and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Reata Pharmaceuticals Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Reata Pharmaceuticals Inc - Ordinary Shares - Class A market cap is $6.57B.
What is the 52-week high for Reata Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Reata Pharmaceuticals Inc - Ordinary Shares - Class A 52 week high is $172.46 as of September 12, 2025.
What is the 52-week low for Reata Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Reata Pharmaceuticals Inc - Ordinary Shares - Class A 52 week low is $21.83 as of September 12, 2025.
What is Reata Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
Reata Pharmaceuticals Inc - Ordinary Shares - Class A stock price today is $172.37.
What was Reata Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
Reata Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday was $172.32.
What is the PE ratio of Reata Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Reata Pharmaceuticals Inc - Ordinary Shares - Class A’s P/E ratio is -57.67.
What is the Price-to-Book ratio of Reata Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Reata Pharmaceuticals Inc - Ordinary Shares - Class A P/B ratio is 74.7302.
What is Reata Pharmaceuticals Inc - Ordinary Shares - Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Reata Pharmaceuticals Inc - Ordinary Shares - Class A's EBITDA is -12.33.
What is the 50-day moving average of Reata Pharmaceuticals Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Reata Pharmaceuticals Inc - Ordinary Shares - Class A 50-day moving average is $163.46.
